Our studies confirm previous findings wherein allogeneic donor T cell proliferation, inflammatory cytokine secretion and DC maturation (23, 26, 27, 49, 50) are suppressed upon BET inhibition, thereby solidifying a therapeutic role for BET inhibitors such as PLX51107 and PLX2853 in acute GVHD. This evidence concerns the gene DNER and acute graft versus host disease.